SMH
LTRN icon

Sanders Morris Harris’s Lantern Pharma LTRN Stock Holding History

Sanders Morris Harris’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-365,930
Closed -$1.72M – 239
2022
Q3 		$1.72M Sell
365,930
-100
-0% -$538 0.42% 39
2022
Q2 		$2.06M Sell
366,030
-18,198
-5% -$109K 0.45% 37
2022
Q1 		$2.75M Buy
384,228
+47,803
+14% +$319K 0.54% 36
2021
Q4 		$2.57M Buy
+336,425
New +$3.07M 0.45% 42

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Morris Harris's LTRN Position: Q4 2022 in Review

Sanders Morris Harris sold out of Lantern Pharma (LTRN) in Q4 2022, closing a stake of 365,930 shares — an estimated $1.72M sold.

Sanders Morris Harris first reported a position in LTRN in Q4 2021 and held it in 4 quarters. The position peaked at $2.75M in Q1 2022. 23 funds tracked by Wall St. Rank hold LTRN as of Q4 2022.

  • Sanders Morris Harris reported no remaining Lantern Pharma position as of Q4 2022 after selling out during the quarter.
  • Sanders Morris Harris sold 365,930 Lantern Pharma shares in Q4 2022, an estimated $1.72M.
  • Sanders Morris Harris first reported a position in Lantern Pharma in Q4 2021 and held it in 4 quarters.
  • Sanders Morris Harris's Lantern Pharma position peaked at $2.75M in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2022.

Based on Sanders Morris Harris's 13F filing for Q4 2022, filed 13 Jan 2023.